Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia

Adult acute lymphoblastic leukemia (ALL) has a poor overall survival compared with pediatric ALL where cure rates are observed in more than 90% of patients. The recent development of novel monoclonal antibodies targeting CD20, CD19, and CD22 has changed the long-term outcome of this disease, both in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Hematol
Asıl Yazarlar: Guerra, Veronica A., Jabbour, Elias J., Ravandi, Farhad, Kantarjian, Hagop, Short, Nicholas J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535741/
https://ncbi.nlm.nih.gov/pubmed/31205644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620719849496
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller